Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Martin

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Brachytherapy|August 25, 2019
The association of intraprostatic calcifications and dosimetry parameters with biochemical control after permanent prostate implantEric Vigneault, Khaly Mbodji, Damien Carignan, et al.
Brachytherapy|December 21, 2004
Dosimetric consequences of manual pullback procedure for coronary artery radiotherapy with 90Sr/90Y beta-sourceIleana Iftimia, Phillip M Devlin, Andre-Guy Martin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2017
High-dose-rate brachytherapy boost for prostate cancer treatment: Different combinations of hypofractionated regimens and clinical outcomesEric Vigneault, Khaly Mbodji, Sindy Magnan, et al.
Annals of Translational Medicine|July 25, 2015
Chromogranin A as a predictor of radiological disease progression in neuroendocrine tumoursRoberta Elisa Rossi, Jorge Garcia-Hernandez, Tim Meyer, et al.
Brachytherapy|July 28, 2020
Evaluating the impact of real-time multicriteria optimizers integrated with interactive plan navigation tools for HDR brachytherapyCédric Bélanger, Éric Poulin, Songye Cui, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 26, 2016
Does prostate volume has an impact on biochemical failure in patients with localized prostate cancer treated with HDR boost?Eric Vigneault, Khaly Mbodji, Marc-Étienne Beaudet, et al.
The Prostate|March 24, 2020
DNA repair gene polymorphisms, tumor control, and treatment toxicity in prostate cancer patients treated with permanent implant prostate brachytherapyDamien Carignan, Trystan Lessard, Lyne Villeneuve, et al.
International Journal of Radiation Oncology, Biology, Physics|September 26, 2006
Bypassing the learning curve in permanent seed implants using state-of-the-art technologyLuc Beaulieu, Dee-Ann Radford Evans, Sylviane Aubin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 19, 2017
External validation of the ProCaRS nomograms and comparison of existing risk-stratification tools for localized prostate cancerDavid Tiberi, George Rodrigues, Tom Pickles, et al.
Brachytherapy|July 9, 2021
PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot studyThomas Reynaud, Lara Hathout, Damien Carignan, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Brachytherapy|August 25, 2019
The association of intraprostatic calcifications and dosimetry parameters with biochemical control after permanent prostate implantEric Vigneault, Khaly Mbodji, Damien Carignan, et al.
Brachytherapy|December 21, 2004
Dosimetric consequences of manual pullback procedure for coronary artery radiotherapy with 90Sr/90Y beta-sourceIleana Iftimia, Phillip M Devlin, Andre-Guy Martin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2017
High-dose-rate brachytherapy boost for prostate cancer treatment: Different combinations of hypofractionated regimens and clinical outcomesEric Vigneault, Khaly Mbodji, Sindy Magnan, et al.
Annals of Translational Medicine|July 25, 2015
Chromogranin A as a predictor of radiological disease progression in neuroendocrine tumoursRoberta Elisa Rossi, Jorge Garcia-Hernandez, Tim Meyer, et al.
Brachytherapy|July 28, 2020
Evaluating the impact of real-time multicriteria optimizers integrated with interactive plan navigation tools for HDR brachytherapyCédric Bélanger, Éric Poulin, Songye Cui, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 26, 2016
Does prostate volume has an impact on biochemical failure in patients with localized prostate cancer treated with HDR boost?Eric Vigneault, Khaly Mbodji, Marc-Étienne Beaudet, et al.
The Prostate|March 24, 2020
DNA repair gene polymorphisms, tumor control, and treatment toxicity in prostate cancer patients treated with permanent implant prostate brachytherapyDamien Carignan, Trystan Lessard, Lyne Villeneuve, et al.
International Journal of Radiation Oncology, Biology, Physics|September 26, 2006
Bypassing the learning curve in permanent seed implants using state-of-the-art technologyLuc Beaulieu, Dee-Ann Radford Evans, Sylviane Aubin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 19, 2017
External validation of the ProCaRS nomograms and comparison of existing risk-stratification tools for localized prostate cancerDavid Tiberi, George Rodrigues, Tom Pickles, et al.
Brachytherapy|July 9, 2021
PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot studyThomas Reynaud, Lara Hathout, Damien Carignan, et al.
Pageof 12